AI Article Synopsis
- Pseudocirrhosis can occur after chemotherapy for breast cancer with liver metastasis, resembling actual liver cirrhosis.
- A study reports on 5 patients treated with eribulin, a chemotherapy drug, who developed pseudocirrhosis during their treatment.
- Although liver metastases shrank significantly early on, these patients ultimately experienced poor health outcomes.
Article Abstract
Pseudocirrhosis, which is radiologically and clinically similar to liver cirrhosis, may develop following chemotherapy for breast cancer with liver metastasis. There are few reports of eribulin treatment. We report 5 patients with metastatic or recurrent breast cancer who developed pseudocirrhosis during eribulin treatment. All patients had diffuse liver metastasis, and the liver metastases significantly reduced in size during the early phase of eribulin treatment, when they developed pseudocirrhosis. Subsequently, the patients had poor prognoses.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
eribulin treatment
16
pseudocirrhosis eribulin
8
breast cancer
8
liver metastasis
8
developed pseudocirrhosis
8
[five cases
4
pseudocirrhosis
4
cases pseudocirrhosis
4
eribulin
4
treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!